| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/12/1997 | EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 03/12/1997 | EP0648207B1 Vitamin d analogues |
| 03/12/1997 | EP0586518B1 Cholesterol-lowering tocopherol analogs |
| 03/12/1997 | EP0422100B1 11 beta-substituted progesterone analogs |
| 03/12/1997 | EP0378671B1 Insulinomimetic and insulin receptor binding site peptides |
| 03/12/1997 | CN1145075A Antagonist's of endothelin receptors |
| 03/12/1997 | CN1145071A Heterocyclic compounds and their preparation and use |
| 03/12/1997 | CN1144801A Beta-Adrenergic agonists |
| 03/11/1997 | US5610183 Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy |
| 03/11/1997 | US5610178 Macrolides and the use thereof |
| 03/11/1997 | US5610172 Sulfonamidocarbonylpyridine-2-carboxamides and pyridine-n-oxides which are useful as pharmaceuticals |
| 03/11/1997 | US5610168 Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 03/11/1997 | US5610161 1-azaspiroalkane derivatives; antidepressants, anxiolytic agents; eating disorders |
| 03/11/1997 | US5610152 Anti-obesity agent 4-cholesten-3-one |
| 03/11/1997 | US5610151 Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 03/11/1997 | EP0699442A4 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
| 03/11/1997 | CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels |
| 03/06/1997 | WO1997008249A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 03/06/1997 | WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes |
| 03/06/1997 | WO1997008126A1 Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents |
| 03/06/1997 | WO1997007814A1 Method and composition for enhanced parenteral nutrition |
| 03/06/1997 | CA2230094A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 03/06/1997 | CA2227691A1 Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents |
| 03/06/1997 | CA2227278A1 Method and composition for enhanced parenteral nutrition |
| 03/05/1997 | EP0760365A2 Alkenyl-benzoylguanidines |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759919A1 New azolidinediones as antihyperglycemic agents |
| 03/05/1997 | EP0759912A1 New di-oxadiazole derivatives as antihyperglycemic agents |
| 03/05/1997 | EP0759776A1 Use of igf-i or analogues thereof in the prevention of diabetes |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759768A1 Vasoactive intestinal polypeptide |
| 03/05/1997 | EP0759745A1 Method and composition for increasing calcium uptake |
| 03/05/1997 | CN1144526A Thiazolidines and oxazolidines substituted by pyridine ring and their use a hypoglycemic agents |
| 03/05/1997 | CN1144522A Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 03/05/1997 | CN1144487A Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
| 03/05/1997 | CN1144483A Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
| 03/05/1997 | CN1144482A Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 03/05/1997 | CN1144480A Guanylhydrazones for treating inflammatory conditions |
| 03/05/1997 | CN1144479A Medical treatment |
| 03/05/1997 | CN1144193A Medicinal water, method of production thereof, and dialysis apparatus using water as dialysis liquid |
| 03/05/1997 | CN1144111A Shuangjie Jiangtangjing capsule |
| 03/05/1997 | CN1144091A Compounds having retinoid-like activity |
| 03/05/1997 | CN1034176C Process for preparation of pharmaceutical compositions for preventing and curing diabetic complication |
| 03/04/1997 | US5608095 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 03/04/1997 | US5608084 And vascular pathologies; multistep preparation by reacting a hydroquinone with alkyl vinyl ketone, esterifying hydroxy 3,4-dihydro-2h-1-benzopyran, demethylating ether, reacting with alkyl 5-bromopentanoate, hydrolyzing, two more steps |
| 03/04/1997 | US5607970 Glycerol monostearate or palmitate |
| 03/04/1997 | US5607960 Indole derivatives as 5-HT1-like agonists for use in migraine |
| 03/04/1997 | US5607954 Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals |
| 03/04/1997 | US5607944 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparations |
| 03/04/1997 | US5607934 Preventing and treating diseases caused by superoxide radicals, nephritis |
| 03/04/1997 | US5607915 Pulmonary delivery of active fragments of parathyroid hormone |
| 03/04/1997 | US5607707 Optically clear products for use in human and animal healthcare |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007120A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists |
| 02/27/1997 | WO1997006816A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/27/1997 | WO1997006814A1 Method of promoting angiogenesis |
| 02/27/1997 | WO1997006790A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | WO1996022095A3 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 02/27/1997 | DE19530865A1 Wirkstoff sowie Mittel zur parenteralen Ernährung Drug and means for parenteral nutrition |
| 02/27/1997 | CA2229450A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229135A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/26/1997 | EP0759294A2 Hypercholesterolemia therapeutic agent |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0758897A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 02/26/1997 | EP0732917A4 Nutritional supplement for optimizing cellular health |
| 02/26/1997 | EP0726715A4 Psyllium containing snack bars, processes for making these, and uses thereof |
| 02/26/1997 | EP0533781B1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| 02/26/1997 | CN1143647A Dipeptides which promote release of growth hormone |
| 02/26/1997 | CN1143643A Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol |
| 02/26/1997 | CN1143639A Oxime derivatives, their preparation and their therapeutic use |
| 02/26/1997 | CN1143632A Fluorine-containing benzoylguanidines |
| 02/26/1997 | CN1143520A Weight-reducing health oral liquid |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605933 Retinoid conjugate compounds and methods for treating of skin aging |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605929 Methods and compositions for inhibiting 5α-reductase activity |
| 02/25/1997 | US5605924 Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes |
| 02/25/1997 | US5605918 Substituted thiazolidine-2,4-diones |
| 02/25/1997 | US5605893 Mixture of carbohydrates, protein and fats |
| 02/25/1997 | US5605886 Anti-obesity proteins |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | CA2183937A1 Alkenyl-benzoylguanidine derivatives |
| 02/25/1997 | CA2046146C Pyrrole derivatives |
| 02/25/1997 | CA2018227C Association of physiologically dosed vitamin a and of various active principles having a therapeutical activity |
| 02/25/1997 | CA1338937C Process for the manufacture of novel substituted alkanediphosphonic acids |
| 02/20/1997 | WO1997005861A1 Calcium-containing agent for intestinal phosphate binding and process for producing it |
| 02/19/1997 | EP0758648A1 Substituted 4H-pyrans with a modulating effect on calcium channels |
| 02/19/1997 | EP0758644A1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758330A1 Biphenylcarboxamides useful as 5-ht1d antagonists |
| 02/19/1997 | EP0758312A1 Substituted fused and bridged bicyclic compounds as therapeutic agents |
| 02/19/1997 | EP0758234A1 Method and composition for treating renal disease and failure |
| 02/19/1997 | CN1143379A Crosslinked polymeric ammonium salts |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |